Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02252770 · ClinicalTrials.gov registry record · NA
Nitric Oxide Supplementation in Argininosuccinic Aciduria
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02252770 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 12 participants.
The verdict
NCT02252770, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a study involving a dietary supplement. Patients with argininosuccinic aciduria will be randomly assigned to receive either a nitric oxide dietary supplement or placebo for 2 weeks, and then crossed-over to receive the other treatment for two weeks. The investigators expect to see that : 1) Patients with ASA will have a decreased ability for their arteries to dilate due to nitric oxide deficiency, 2) Treatment of ASA with the nitric oxide supplement will improve the ability of their arteries to dilate, and 3) Through the testing of subjects' fibroblasts (cells in connective tissue that produce collagen and other fibers), the investigators hope to predict which patients may respond NO supplementation.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Nitric oxide supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-09 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02252770
The ClinicalTrials.gov registry entry for NCT02252770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02252770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02252770 about?
NCT02252770 is a clinical study titled "Nitric Oxide Supplementation in Argininosuccinic Aciduria". This is a study involving a dietary supplement. Patients with argininosuccinic aciduria will be randomly assigned to receive either a nitric oxide dietary supplement or placebo for 2 weeks, and then crossed-over to receive the other treatment for two weeks. The investigators expect to see that : 1)...
What is the current status of trial NCT02252770?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-09. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02252770?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Nitric oxide supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02252770?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.